Timothy John Martin, MD | |
Medical Center Blvd, Winston Salem, NC 27157-0001 | |
(336) 716-2255 | |
(336) 716-7994 |
Full Name | Timothy John Martin |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 38 Years |
Location | Medical Center Blvd, Winston Salem, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053394767 | NPI | - | NPPES |
3500 | Other | NC | PARTNERS |
45602 | Other | NC | MEDCOST |
8954429 | Medicaid | NC | |
Q34084 | Medicaid | SC | |
6324207 | Medicaid | VA | |
54429 | Other | NC | BCBS |
5735102 | Other | AETNA | |
9840171000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 34084 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Carolina Baptist Hospital | Winston-salem, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wake Forest University Health Sciences | 4486564952 | 1987 |
News Archive
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment.
Science has long known that recovery from experimental heart attacks is improved by injection of a mixture of heart muscle cells, endothelial cells and smooth muscle cells, yet results have been limited by poor engraftment and retention, and researchers worry about potential tumorigenesis and heart arrhythmia.
The first study to demonstrate that obesity can directly accelerate the progression of acute lymphoblastic leukemia (ALL) has been conducted at The Saban Research Institute of Childrens Hospital Los Angeles and was published in Cancer Prevention Research, on October 5, 2010.
› Verified 6 days ago
Entity Name | Wake Forest University Health Sciences |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment.
Science has long known that recovery from experimental heart attacks is improved by injection of a mixture of heart muscle cells, endothelial cells and smooth muscle cells, yet results have been limited by poor engraftment and retention, and researchers worry about potential tumorigenesis and heart arrhythmia.
The first study to demonstrate that obesity can directly accelerate the progression of acute lymphoblastic leukemia (ALL) has been conducted at The Saban Research Institute of Childrens Hospital Los Angeles and was published in Cancer Prevention Research, on October 5, 2010.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Timothy John Martin, MD Po Box 344, Winston Salem, NC 27102-0344 Ph: (336) 716-2255 | Timothy John Martin, MD Medical Center Blvd, Winston Salem, NC 27157-0001 Ph: (336) 716-2255 |
News Archive
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment.
Science has long known that recovery from experimental heart attacks is improved by injection of a mixture of heart muscle cells, endothelial cells and smooth muscle cells, yet results have been limited by poor engraftment and retention, and researchers worry about potential tumorigenesis and heart arrhythmia.
The first study to demonstrate that obesity can directly accelerate the progression of acute lymphoblastic leukemia (ALL) has been conducted at The Saban Research Institute of Childrens Hospital Los Angeles and was published in Cancer Prevention Research, on October 5, 2010.
› Verified 6 days ago
Dr. Henry Warren Burnett, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Oakwood Dr Ste 380, Winston Salem, NC 27103 Phone: 336-765-3930 Fax: 336-765-3483 | |
Frank Joseph Moya, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1340 Creekshire Way, Winston Salem, NC 27103 Phone: 919-620-4467 | |
Phillip Mckinley, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2025 Frontis Plaza Blvd Ste 100, Winston Salem, NC 27103 Phone: 919-620-4467 | |
Craig Michael Greven, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2255 Fax: 336-716-7994 | |
Dr. Kirk A Murdock, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 725 Highland Oaks Dr, Suite 101, Winston Salem, NC 27103 Phone: 336-659-8180 Fax: 336-659-8363 | |
Dr. Andrew Yin Chu Ting, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2255 Fax: 336-716-7994 |